MMSI Insider Filing: Ward Reports Option Exercise and Share Sale on 08/11/2025

Rhea-AI Filing Summary

Lynne N. Ward, a director of Merit Medical Systems (MMSI), reported transactions dated 08/11/2025 on a Form 4. The filing shows the exercise of non-qualified stock options with an exercise price of $34.46 and an associated acquisition of 2,433 shares, and a contemporaneous sale of 2,433 shares at $84.8894.

Following the reported activity the form lists non-derivative beneficial ownership figures of 15,242 and 12,809 shares (as reported on separate lines) and indicates 3,000 derivative securities beneficially owned after the transactions, with 5,433 underlying common shares referenced for the options. The form is signed by an attorney-in-fact on 08/12/2025.

Insights

Securities Analyst

TL;DR: Routine option exercise and simultaneous sale reported; transaction details clearly disclosed.

The Form 4 documents an option exercise at an exercise price of $34.46 and the acquisition of 2,433 shares, followed by a sale of 2,433 shares at $84.8894 on 08/11/2025. Post-transaction holdings are reported as 15,242 and 12,809 common shares on separate non-derivative lines, and 3,000 derivative securities remain beneficially owned with 5,433 underlying shares noted. For investors, this is a clear, standard disclosure of insider option exercise and sale with explicit prices and quantities; there is no additional financial or operational information in this filing to change valuation models.

Corporate Governance Expert

TL;DR: Insider exercise and sale properly disclosed; signature by an attorney-in-fact is noted.

The reporting person is identified as Director Lynne N. Ward. The Form 4 is completed and signed by an attorney-in-fact (Brian G. Lloyd) on 08/12/2025, and it includes an explanation that the options "become exercisable in equal annual installments of 33% commencing 08/28/2020." The filing meets Section 16 disclosure requirements by itemizing exercise price, sale price, quantities, and resulting beneficial ownership. From a governance perspective, this is a routine, compliant insider disclosure without other governance events disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ward Lynne N.

(Last) (First) (Middle)

1600 WEST MERIT PARKWAY

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	08/11/2025		M		2,433	A	$34.46	15,242	D
Common Stock, No Par Value	08/11/2025		S		2,433	D	$84.8894	12,809	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified stock options (right to buy)	$34.46	08/11/2025		M			2,433	08/28/2020(1)	08/28/2026	Common Stock	5,433	$0	3,000	D

Explanation of Responses:

1. Becomes exercisable in equal annual installments of 33% commencing 08/28/2020.

	/s/ Brian G. Lloyd, Attorney-in-Fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Merit Medical Systems (MMSI)?

The reporting person is Lynne N. Ward, identified as a Director of Merit Medical Systems.

What transactions are reported on the MMSI Form 4 dated 08/11/2025?

The Form reports the exercise of non-qualified stock options (exercise price $34.46) with an acquisition of 2,433 shares and a contemporaneous sale of 2,433 shares at $84.8894.

How many shares and options are reported as beneficially owned after the transactions?

The filing lists non-derivative beneficial ownership figures of 15,242 and 12,809 shares on separate lines, and 3,000 derivative securities beneficially owned following the transactions, with 5,433 underlying common shares noted for the options.

When were the transactions executed and when was the Form 4 signed?

Transactions are dated 08/11/2025, and the Form 4 is signed by an attorney-in-fact on 08/12/2025.

What is the exercisability schedule shown for the options?

The explanation states the options "become exercisable in equal annual installments of 33% commencing 08/28/2020."